Theralase Technologies Inc. is a Canada-based designer, developer, manufacturer and marketer of super-pulsed laser technology used in biostimulative and biodestructive clinical applications. The Company's technology platform targets healthcare sectors: for non-invasive pain management and clinical therapy, used in neural muscular skeletal conditions, including arthritis and osteoarthritis; wound care and healing, and research and development (R&D) into combining patented photodynamic compounds with patented, super-pulsed, biofeedback laser technology to attack targeted cancers, bacteria and viruses. The Company is organized into two operating divisions. The Therapeutic Laser Technology division is responsible for all aspects of the Company's therapeutic laser business. The Photo Dynamic Therapy division is responsible for the R&D of Photo Dynamic Compounds (PDCs) for the destruction of primarily cancer.